RIVASTIGMINE

Rivastigmine is a cholinesterase inhibitor used for Alzheimers and Parkinsons dementia. Side effects include nausea, vomiting, weight loss, tremor, dizziness, and bradycardia. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 94a0e3273e15 Category: Tag:

Product Description


Mechanism of Action

RIVASTIGMINE engages in multilayer biochemical interactions affecting enzyme cascades, receptorregulated signalling, oxidativestress systems, mitochondrial respiration, ionchannel dynamics, cytoskeletal mechanics and transcriptionfactor pathway coordination. Molecularmodelling parameters suggest potential interactions with catalytic centres, allosteric microdomains, transmembrane receptor helices, cofactorbinding regions, and structural scaffolding proteins. These interactions enable modulation of phosphorylation cycles, secondmessenger amplification (Ca²⁺, cAMP, IP, DAG), ATP turnover, mitochondrial membrane potential and ROS balancing capacity.

Benefits and Applications

  • Receptorligand affinity mapping and molecular docking
  • Enzymekinetic pathway modelling and catalyticflux analysis
  • Mitochondrial bioenergetics profiling and redoxstate research
  • Multiomics studies (transcriptomics, metabolomics, proteomics)
  • Cytoskeletal architecture analysis and membranedynamics modelling
  • Apoptosis, necroptosis, autophagy and ferroptosis pathway assays
  • SAR and QSARdriven molecular optimisation
  • Pharmacodynamic and mechanistic doseresponse modelling

Risks & Side Effects

  • Oxidative imbalance and ROS escalation
  • Mitochondrial overload or suppression of respiratory complexes
  • Ionchannel destabilisation (Na⁺/K⁺/Ca²⁺)
  • Unintended receptor crosstalk
  • Cytoskeletal destabilisation
  • Dosedependent cytotoxicity or programmed-cell-death activation
  • Inflammatory transcriptional activation (NF-κB, JNK, MAPK)

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C14H22N2O2

Molecular Weight

250.34 g/mol

CAS Number

123441-03-2

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

2.04e+00 g/L

Purity

Purity information is available upon request (COA).

Synonym

rivastigmine; 123441-03-2; Prometax; ENA 713 free base; Nimvastid

IUPAC/Chemical Name

[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate

InChl Key

XSVMFMHYUFZWBK-NSHDSACASA-N

InChl Code

InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/77991;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download